141 related articles for article (PubMed ID: 36226871)
1. TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions.
Tian P; Wu L; Kudo M; Hayashi M; Qin L; Gao M; Xu A; Liu T
Pharm Biol; 2022 Dec; 60(1):2002-2010. PubMed ID: 36226871
[TBL] [Abstract][Full Text] [Related]
2. Tang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr rats.
Li L; Yoshitomi H; Wei Y; Qin L; Zhou J; Xu T; Wu X; Zhou T; Sun W; Guo X; Wu L; Wang H; Zhang Y; Li C; Liu T; Gao M
PLoS One; 2015; 10(4):e0122024. PubMed ID: 25874615
[TBL] [Abstract][Full Text] [Related]
3. Tangnaikang improves insulin resistance and β-cell apoptosis by ameliorating metabolic inflammation in SHR.Cg-Leprcp/NDmcr rats.
Li L; Qin L; Wu X; Wang H; Jiang Y; Wei Y; Xu T; Liu T; Yoshitomi H; Gao M; Zhou T
J Tradit Chin Med; 2017 Jun; 37(3):361-370. PubMed ID: 31682379
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic effects of Tangnaikang on obese Zucker rats and the mechanism.
Guo XY; Duan Y; Li JE; Yang LX; Huang LS; Wang ZC; Wang HY; Liu TH
Zhong Xi Yi Jie He Xue Bao; 2010 Jun; 8(6):535-40. PubMed ID: 20550875
[TBL] [Abstract][Full Text] [Related]
5. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
6. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
7. Changes in gut microbiota and short-chain fatty acids are involved in the process of canine obesity after neutering.
Yang K; Lin X; Jian S; Wen J; Jian X; He S; Wen C; Liu T; Qi X; Yin Y; Deng B
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37632755
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
9. Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions.
Zhang Y; Lou JW; Kang A; Zhang Q; Zhou SK; Bao BH; Cao YD; Yao WF; Tang YP; Zhang L
J Ethnopharmacol; 2020 Mar; 249():112423. PubMed ID: 31765764
[TBL] [Abstract][Full Text] [Related]
10. Probiotic yogurt blunts the increase of blood pressure in spontaneously hypertensive rats
Kong CY; Li ZM; Mao YQ; Chen HL; Hu W; Han B; Wang LS
Food Funct; 2021 Oct; 12(20):9773-9783. PubMed ID: 34494630
[TBL] [Abstract][Full Text] [Related]
11. Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats.
Dong S; Liu Q; Zhou X; Zhao Y; Yang K; Li L; Zhu D
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677668
[TBL] [Abstract][Full Text] [Related]
12. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
14. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
Tian J; Bai B; Gao Z; Yang Y; Wu H; Wang X; Wang J; Li M; Tong X
Front Cell Infect Microbiol; 2021; 11():740236. PubMed ID: 34692563
[TBL] [Abstract][Full Text] [Related]
15. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acid alleviates glycolipid metabolic disorders by modulating intestinal microbiota and short-chain fatty acids in obese rats.
Li W; Fu X; Lin D; Li T; Zhang N; Huo Y; Zhu P; Guo F; Huang F
Food Funct; 2023 Feb; 14(3):1685-1698. PubMed ID: 36692407
[TBL] [Abstract][Full Text] [Related]
17. Gancao-Gansui combination impacts gut microbiota diversity and related metabolic functions.
Yu J; Guo J; Tao W; Liu P; Shang E; Zhu Z; Fan X; Shen J; Hua Y; Zhu KY; Tang Y; Duan JA
J Ethnopharmacol; 2018 Mar; 214():71-82. PubMed ID: 29198875
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the gut microbiota can elicit hypertension in rats.
Adnan S; Nelson JW; Ajami NJ; Venna VR; Petrosino JF; Bryan RM; Durgan DJ
Physiol Genomics; 2017 Feb; 49(2):96-104. PubMed ID: 28011881
[TBL] [Abstract][Full Text] [Related]
19. Improvement in cardiometabolic risk markers following an oatmeal diet is associated with gut microbiota in mildly hypercholesterolemic individuals.
Xu D; Pan D; Liu H; Yang C; Yang X; Wang X; Liu F; Feng M; Wu Q; Shen Y; Yang L; Wang S; Sun G
Food Res Int; 2022 Oct; 160():111701. PubMed ID: 36076452
[TBL] [Abstract][Full Text] [Related]
20. Changes in gut microbiota, metabolite SCFAs, and GPR43 expression in obese diabetic mice after sleeve gastrectomy.
Guo Y; Liu C; Zhao X; Zhang X; Wu Q; Wang Z; Lu J
J Appl Microbiol; 2022 Aug; 133(2):555-568. PubMed ID: 35437874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
